drug
as of 2026-07-01MK5757
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Merck Sharp & Dohme LLC
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)
NCT00848484Phase 2Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
indication
indication
indication